Cargando…
A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review
BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641775/ https://www.ncbi.nlm.nih.gov/pubmed/37965164 http://dx.doi.org/10.3389/fneur.2023.1269237 |
_version_ | 1785146827914346496 |
---|---|
author | Sun, Lei Lin, Weihong Meng, Hongmei Zhang, Wuqiong Hou, Shuai |
author_facet | Sun, Lei Lin, Weihong Meng, Hongmei Zhang, Wuqiong Hou, Shuai |
author_sort | Sun, Lei |
collection | PubMed |
description | BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest at any age. A subtype of leukodystrophy, associated with missense mutations in the RNA polymerase subunit III (POLR3A) gene, is inherited in an autosomal recessive manner. CASE REPORT: We report and analyse a case of a 34-year-old female who presented with ataxia. Magnetic Resonance Imaging (MRI) of the brain revealed demyelinating lesions in the white matter. Genetic testing identified the c.4044C > G and c.1186-2A > G variants in the POLR3A gene. The patient was diagnosed with hypomyelinating leukodystrophy type 7 and received neurotrophic and symptomatic supportive therapy. However, after 1 month of follow-up, there was no improvement in her symptoms. CONCLUSION: POLR3A-induced leukodystrophy is relatively rare and not well understood, making it challenging to diagnose and easy to overlook. The prognosis for this disease is generally poor, significantly impacting the quality of life of affected individuals. Currently, no cure is available for this condition, and treatment is limited to managing symptoms. Further research into new treatment methods for POLR3A-induced leukodystrophy is imperative to improve the quality of life and potentially extend the life expectancy of patients. |
format | Online Article Text |
id | pubmed-10641775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106417752023-11-14 A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review Sun, Lei Lin, Weihong Meng, Hongmei Zhang, Wuqiong Hou, Shuai Front Neurol Neurology BACKGROUND: Leukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest at any age. A subtype of leukodystrophy, associated with missense mutations in the RNA polymerase subunit III (POLR3A) gene, is inherited in an autosomal recessive manner. CASE REPORT: We report and analyse a case of a 34-year-old female who presented with ataxia. Magnetic Resonance Imaging (MRI) of the brain revealed demyelinating lesions in the white matter. Genetic testing identified the c.4044C > G and c.1186-2A > G variants in the POLR3A gene. The patient was diagnosed with hypomyelinating leukodystrophy type 7 and received neurotrophic and symptomatic supportive therapy. However, after 1 month of follow-up, there was no improvement in her symptoms. CONCLUSION: POLR3A-induced leukodystrophy is relatively rare and not well understood, making it challenging to diagnose and easy to overlook. The prognosis for this disease is generally poor, significantly impacting the quality of life of affected individuals. Currently, no cure is available for this condition, and treatment is limited to managing symptoms. Further research into new treatment methods for POLR3A-induced leukodystrophy is imperative to improve the quality of life and potentially extend the life expectancy of patients. Frontiers Media S.A. 2023-10-27 /pmc/articles/PMC10641775/ /pubmed/37965164 http://dx.doi.org/10.3389/fneur.2023.1269237 Text en Copyright © 2023 Sun, Lin, Meng, Zhang and Hou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Sun, Lei Lin, Weihong Meng, Hongmei Zhang, Wuqiong Hou, Shuai A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title | A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title_full | A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title_fullStr | A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title_full_unstemmed | A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title_short | A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review |
title_sort | chinese patient with polr3a-related leukodystrophy: a case report and literature review |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641775/ https://www.ncbi.nlm.nih.gov/pubmed/37965164 http://dx.doi.org/10.3389/fneur.2023.1269237 |
work_keys_str_mv | AT sunlei achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT linweihong achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT menghongmei achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT zhangwuqiong achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT houshuai achinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT sunlei chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT linweihong chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT menghongmei chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT zhangwuqiong chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview AT houshuai chinesepatientwithpolr3arelatedleukodystrophyacasereportandliteraturereview |